Basu, Devraj <br/><br/>
EGFR inhibition promotes an aggressive invasion pattern mediated by mesenchymal-like tumor cells within squamous cell carcinomas.  [electronic resource] 

 -  Molecular cancer therapeutics  Oct 2013 
 - 2176-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-12-1210  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Cadherins--genetics<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Line, Tumor<br/>Cell Lineage<br/>Cetuximab<br/>Epithelial-Mesenchymal Transition--genetics<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Mesoderm--cytology<br/>Neoplasm Invasiveness--genetics<br/>Quinazolines--administration & dosage<br/>Spheroids, Cellular--cytology<br/>Xenograft Model Antitumor Assays